Literature DB >> 23552867

Antihypertensive and renoprotective effect of the kinin pathway activated by potassium in a model of salt sensitivity following overload proteinuria.

Leopoldo Ardiles1, Areli Cardenas, María E Burgos, Alejandra Droguett, Pamela Ehrenfeld, Daniel Carpio, Sergio Mezzano, Carlos D Figueroa.   

Abstract

The albumin overload model induces proteinuria and tubulointersitial damage, followed by hypertension when rats are exposed to a hypersodic diet. To understand the effect of kinin system stimulation on salt-sensitive hypertension and to explore its potential renoprotective effects, the model was induced in Sprague-Dawley rats that had previously received a high-potassium diet to enhance activity of the kinin pathway, followed with/without administration of icatibant to block the kinin B₂ receptor (B₂R). A disease control group received albumin but not potassium or icatibant, and all groups were exposed to a hypersodic diet to induce salt-sensitive hypertension. Potassium treatment increased the synthesis and excretion of tissue kallikrein (Klk1/rKLK1) accompanied by a significant reduction in blood pressure and renal fibrosis and with downregulation of renal transforming growth factor-β (TGF-β) mRNA and protein compared with rats that did not receive potassium. Participation of the B₂R was evidenced by the fact that all beneficial effects were lost in the presence of the B₂R antagonist. In vitro experiments using the HK-2 proximal tubule cell line showed that treatment of tubular cells with 10 nM bradykinin reduced the epithelial-mesenchymal transdifferentiation and albumin-induced production of TGF-β, and the effects produced by bradykinin were prevented by pretreatment with the B₂R antagonist. These experiments support not only the pathogenic role of the kinin pathway in salt sensitivity but also sustain its role as a renoprotective, antifibrotic paracrine system that modulates renal levels of TGF-β.

Entities:  

Keywords:  TGF-β; bradykinin; bradykinin B2 receptor; kallikrein; potassium; renoprotection

Mesh:

Substances:

Year:  2013        PMID: 23552867     DOI: 10.1152/ajprenal.00604.2012

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  3 in total

1.  Low-density lipoprotein apheresis ameliorates monthly estimated glomerular filtration rate declines in patients with renal cholesterol crystal embolism.

Authors:  Keiji Hirai; Susumu Ookawara; Haruhisa Miyazawa; Kiyonori Ito; Yuichirou Ueda; Yoshio Kaku; Taro Hoshino; Izumi Yoshida; Kaoru Tabei
Journal:  J Artif Organs       Date:  2014-11-04       Impact factor: 1.731

2.  Conditional knockout of collecting duct bradykinin B2 receptors exacerbates angiotensin II-induced hypertension during high salt intake.

Authors:  Libor Kopkan; Zuzana Husková; Šárka Jíchová; Lenka Červenková; Luděk Červenka; Zubaida Saifudeen; Samir S El-Dahr
Journal:  Clin Exp Hypertens       Date:  2015-07-07       Impact factor: 1.749

3.  Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population.

Authors:  Lyanne M Kieneker; Michele F Eisenga; Michel M Joosten; Rudolf A de Boer; Ron T Gansevoort; Jenny E Kootstra-Ros; Gerjan Navis; Stephan J L Bakker
Journal:  PLoS One       Date:  2017-03-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.